期刊
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
卷 38, 期 6, 页码 659-665出版社
TAYLOR & FRANCIS AS
DOI: 10.1080/00365520310002300
关键词
chronic hepatitis C; interferon; MMP-2 (metalloproteinase-2); PIIINP (N-terminal propeptide of type III procollagen); ribavirin; TIMP-1 (tissue inhibitor of metalloproteinase-1); YKL-40
Background: The possible markers of liver fibrosis (plasma YKL-40, PIIINP, MMP-2 and TIMP-1) were measured at the start (t0) and end of treatment (t12) with alpha-interferon and ribavirin and repeated at-6-months follow-up (t18) in 51 patients with chronic hepatitis C. Methods: We evaluated 1) whether treatment response is reflected by a decrease in these markers during antiviral therapy; 2) whether these markers reflect the activity of the disease; and 3) whether these markers could be used as predictors of the treatment response. Results: Baseline plasma YKL-40, MMP-2, PIIINP and TIMP-1 were significantly increased in patients compared to normal controls. In responders (n=30), plasma YKL-40 (P<0.05), MMP-2 (P<0.05) and TIMP-1 ( P<0.001) decreased significantly at t18, and no changes were observed at t12. Plasma PIIINP was unchanged in responders. In non-responders (n=19), plasma MMP-2 (P<0.01) and TIMP-1 (P<0.01) decreased significantly at t18, whereas plasma YKL-40 and PIIINP were unchanged. The markers were significantly correlated at baseline (P<0.001). Plasma PIIINP at baseline could predict treatment response (P=0.01). Conclusions: Response to antiviral treatment is associated with a decrease in the fibrogenetic markers, but the markers do not reflect the biochemical disease activity during treatment. Baseline plasma PIIINP was the only marker predicting treatment response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据